cancer stem cell growth inhibitor (Haimbio)

N/A

Report date: 2025/01/26 18:53:02
NME

Base Information

Drug Namecancer stem cell growth inhibitor (Haimbio)
Drug Alias Namecancer stem cell growth inhibitor (Haimbio)
ClassificationSmall molecules
Mechanisms of ActionStem cells inhibitors
TargetsUpdating
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHaim Bio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHaim Bio Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A